BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, September 12, 2024
See today's BioWorld Asia
Home
» In the clinic for April 19-25, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
In the clinic for April 19-25, 2022
April 26, 2022
No Comments
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Arcturus, Astrazeneca, Beigene, Clover, Emergex Vaccines, Moderna, Novartis, Novavax, Revive, Takeda, TFF, Urovant Sciences.
BioWorld Asia
Briefs
In the clinic